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An in vivo model of CELF-mediated alternative splicing regulation
in skeletal muscle
Dara S. Berger, Andrea N. Ladd
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Cleveland, Ohio, USA
Members of the CUG-BP and ETR-3-like factor (CELF) family have
been shown to regulate pre-mRNA alternative splicing in striated
muscle. To study the role of CELF-mediated alternative splicing in
developing skeletal muscle, transgenic mice (Myo-CELFΔ) have been
generated that express a nuclear dominant negative CELF protein
(NLSCELFΔ) under the skeletal muscle-speciﬁc myogenin promoter.
This approach was previously used to demonstrate that normal CELF-
mediated splicing is required in heart muscle for healthy cardiac
function. Primary screening was preformed on excised breast muscle
from Myo-CELFΔ transgenic animals. Protein samples were analyzed
for NLSCELFΔ dominant negative protein expression via western
blotting. Furthermore we examined histology from wild-type and
transgenic limbs to observe muscle and ﬁber organization. We found
expression of NLSCELFΔ protein in multiple skeletal muscle groups,
including shoulder, extensor muscles (back front limb), diaphragm
and neck muscles. Preliminary experiments suggest that muscle ﬁber
organization is more compact in transgenic animals, and individual
ﬁber size is smaller when compared to wild-type animals. Our
phenotype suggests CELF splicing regulation is important in muscle
development, therefore further analyses of muscle-speciﬁc alternative
splicing and muscle ﬁber type are being conducted.
doi:10.1016/j.ydbio.2008.05.374
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Endothelial responsiveness of Ptf1a and other genes in liver and
dorsal pancreas progenitors
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Pancreas and liver speciﬁcation require inductive signals from
variousmesodermal cell types. During liver development, interactions
between endothelial cells and newly speciﬁed hepatic endoderm cells
are crucial for the latter's subsequent growth and morphogenesis into
a liver bud. In vitro reconstitution of this effect with embryonic tissues
demonstrates that endothelial signaling is independent of the blood
supply. During pancreas development, endothelial cells promote the
induction of Ptf1a, a crucial pancreatic determination factor, in Pdx-1-
positive endoderm. Endothelial cells also have a later effect on the
pancreatic endoderm by promoting the survival of the dorsal
mesenchyme, which produces factors that support the pancreatic
endoderm. We are developing an embryonic DNase-chip approach to
detect hypersensitivity differences in Ptf1a and other genes in dorsal
pancreatic and liver buds between Flk1−/− embryos, which lack
endothelial cells, and wild-type embryos. This chromatin-based
assay will allow us to identify endothelial-responsive elements in
endothelial-responsive genes. Identifying such a region will allow us
to identify transcription factors and inductive pathways that are
responsible for transducing signals from endothelial cells. This
genome-wide approach will also allow us to identify additional
genes that may be responsive to endothelial cell signals and that may
thus play a role in liver and pancreatic development.
doi:10.1016/j.ydbio.2008.05.375
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The homeodomain transcription factor Nkx2.2 is essential for
pancreatic islet development and islet cell type differentiation; Nkx2.2
null mutations lead to a misspeciﬁcation of islet cell types. To
understand the molecular role of Nkx2.2 in islet cell speciﬁcation, it
will be important to identify direct transcriptional targets that
regulate this important developmental process. We initially identiﬁed
the bHLH transcription factor, NeuroD1, as a possible target of Nkx2.2.
NeuroD1 also plays a role in islet cell development and β cell
maintenance, and its expression is reduced in islets of Nkx2.2 mutant
mice after e12.5. Interestingly, reporter assays in pancreatic cell lines
indicate cell-type speciﬁc regulatory relationships between Nkx2.2
and Ngn3, another essential islet regulatory factor, on the NeuroD1
promoter. In addition, we are using chromatin immunoprecipitation
technologies combined with the mouse genome-wide arrays (Agilent
and Kaestner, UPenn) to identify novel targets of Nkx2.2. Initial
expression arrays comparing e13.5 wildtype and Nkx2.2 KO pancreata
identiﬁed a tetraspanin family member, Tm4sf4, that is greatly
upregulated during development of the Nkx2.2 KO pancreas. Inter-
estingly, in the developing wild type pancreas Tm4sf4 expression is
localized to the epithelial compartment that harbors the islet
progenitor cells. We are currently investigating how Tm4sf4 may be
involved in islet cell fate decisions. Determination of Nkx2.2 targets
and its molecular interactions will enhance our understanding of the
transcriptional network and regulatory mechanisms necessary for
proper islet cell type speciﬁcation.
doi:10.1016/j.ydbio.2008.05.376
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Identiﬁcation and characterization of novel Fgf17 enhancers
active in the rostral forebrain signaling center
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Secreted signals from rostral, dorsal, lateral, and ventral signaling
centers initiate and support region-speciﬁc developmental programs
in the vertebrate forebrain. These programs transform the anterior
neuroepithelium into distinct forebrain structures (e.g. basal ganglia,
cerebral cortex, hypothalamus). Fgf17, one of four Fgfs required in the
rostral forebrain signaling center (RFSC), is required for regional
development of the dorsal frontal cortex and for select cognitive and
behavioral functions. To elucidate how Fgf17 is regulated in the RFSC,
we used comparative genomics and transgenics to screen highly
conserved genomic elements proximal to the human Fgf17 locus for
enhancer activity. We identiﬁed two enhancers that drive expression
in the Fgf17-positive region of the mouse RFSC: one is active solely in
the RFSC, while the other is also active in the midbrain/hindbrain
signaling center. We have generated transgenic mice in which these
enhancers drive expression of Cre-IRES2-eGFP, and are using these
animals to characterize the developmental activity of both enhancers.
This will illuminate spatial and temporal contexts in which the
enhancers likely regulate Fgf17 transcription, and will lay the ground-
work for future conditional mutagenesis experiments using these
novel transgenic lines. Future studieswill identify transcription factors
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